期刊文献+

人TOP2A单克隆抗体的制备与初步应用 被引量:1

Preparation, identification and preliminary application of monoclonal antibodies against TOP2A
下载PDF
导出
摘要 目的制备抗TOP2A(DNA拓扑异构酶Ⅱ型α)单克隆抗体并对其生物学特性进行鉴定。方法应用分子生物学技术构建含人TOP2A编码序列的原核表达载体,表达并纯化人TOP2A蛋白。TOP2A蛋白皮下多点和腹腔注射加强免疫Balb/c小鼠,取脾与小鼠骨髓瘤细胞SP2/0进行融合,利用间接ELISA方法筛选杂交瘤细胞,采用有限稀释法进行亚克隆,用免疫印迹法、免疫组化染色和流式细胞术对抗体进行特异性鉴定。结果获得了3株能够稳定分泌TOP2A单克隆抗体的杂交瘤细胞,分别命名为11G5、3B10和10A3,通过免疫印迹、免疫组化和流式结果验证均为阳性。结论成功制备TOP2A单克隆抗体,为进一步的TOP2A蛋白的表达与肿瘤的关系研究奠定了基础。 To prepare and identify the monoclonal antibody against TOP2 A, human TOP2 A was expressed and purified by molecular biology techniques, and then used to immunize Balb/c mice. Hybridism cell line secreting antibodies against human TOP2 A was determined by indirect ELISA(enzyme-linked immunosorbent assay) and limiting dilution assay; the specificity of monoclonal antibodies against human TOP2 A was evaluated with Western blot, immunohistochemical staining and flow cytometry, and the results indicated that all raised monoclonal antibodies could specifically react with human TOP2 A. The success in production of TOP2 A monoclonal antibody provides a foundation for evaluating the relationship between of TOP2 A and tumor.
出处 《免疫学杂志》 CAS CSCD 北大核心 2014年第12期1100-1103,1117,共5页 Immunological Journal
关键词 TOP2A 原核表达 单克隆抗体 TOP2A Prokaryotic expression Monoclonal antibody
  • 相关文献

参考文献10

  • 1Park K, Han S, Gwak GH, et al. Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer[J]. Breast Cancer Res Treat, 2006, 98(3): 337-342.
  • 2Liu JM, Chen LT, Li AF, et al. Prognostic implications of the expression of erbB2, topoisomerase llot and thymidylate synthase in metastatic gastric cancer after fluorouracil-based therapy[J]. Jpn J Clin Oncol, 2004, 34(12): 727-732.
  • 3Parker LP, Taylor DD, Kesterson S, et al. Gene expression profiling in response to estradiol and genistein in ovarian cancer cells[J]. Cancer Genomics Proteomics, 2009, 6(3): 189-194.
  • 4Vails A, Wolf M, Monni O, et al. Targets of gene amplification and overexpression at 17q in gastric cancer[J]. Cancer Res, 2002, 62(9): 2625-2629.
  • 5Xu W. Monoclonal antibody against glypican-3 [J]. Hybridism, 2012, 31(6): 475-475.
  • 6Shapiro HM. Practical flow eytometry [M]. John Wiley & Sons, 2005.
  • 7Konecny GE, Pauletti G, Unteh M, et al. Association between HER2, TOP2A, and response to anthracycline- based preoperative chemotherapy in high-risk primary breast cancer[J]. Breast Cancer Res Treat, 2010, 120(2):481-489.
  • 8Liang Z, Zeng X, Gao J, et al. Analysis of EGFR, HER2, and TOP2A gene status and chromosomal polysomy in gastric adenocarcinoma from Chinese patients [J]. BMC Cancer, 2008, 8(1): 363.
  • 9Nakopoulou L, Zervas A, Lazaris AC, et al. Predictive value of Topoisomerase IIα imrnunostaining in urothelial bladder carcinoma[J]. J Clin Pathol, 2001, 54(4): 309-313.
  • 10Kim E J, Lee YS, Kim YJ, et al. Clinical implications and prognostic values of topoisomerase-II alpha expression in primary non - muscle-invasive bladder cancer[J]. Urology, 2010, 75(6): 1516. e9-13.

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部